-Reuters
Why Are Idera Pharmaceuticals Shares Soaring Today
Idera Pharmaceuticals Inc (NASDAQ:IDRA) shared positive interim results from its investigator-sponsored Phase 2 trial, INTRIM 1, involving tilsotolimod, Idera’s synthetic Toll-like…
Related Posts
This Analyst Sees ‘Multiple Catalysts’ To Drive Revenue Growth For Yatra
H.C. Wainwright analyst Scott Buck reiterated a Buy rating on the shares of Yatra Online Inc (NASDAQ:YTRA) with a price target of $4.…
Facebook Just Gave Up On Making Millions From NFTs
Meta Platforms Inc (NASDAQ: META), formerly known as Facebook, announced Monday that it will stop working on digital
Invest In The Future Of Medicine Says Berner, CEO Of Cookies At Benzinga’s Psychedelics Capital Conference
Berner, the famed rapper, co-founder and CEO of the highly successful cannabis and clothing brand, Cookies, was one of the main speakers at Benzinga's Psychedelics Capital Conference last April at the Fontainebleau Miami Beach Hotel.